• N Auestad, R Halter, R T Hall, M Blatter, M L Bogle, W Burks, J R Erickson, K M Fitzgerald, V Dobson, S M Innis, L T Singer, M B Montalto, J R Jacobs, W Qiu, and M H Bornstein.
• Ross Products Division, Abbott Labs, Columbus, Ohio 43215, USA. nancy.auestad@rossnutrition.com
• Pediatrics. 2001 Aug 1; 108 (2): 372-81.

ObjectiveTo evaluate the effects of dietary intake of the long-chain polyunsaturated fatty acids, arachidonic acid (AA), and docosahexaenoic acid (DHA) on multiple indices of infant growth and development.DesignA double-masked, randomized, parallel trial was conducted with term infants fed formulas with or without AA+DHA for 1 year (N = 239). Reference groups of breastfed infants (N = 165) weaned to formulas with and without AA+DHA were also studied. Infants in the formula groups were randomized at ResultsAA and DHA levels in plasma and red cells were higher in AA+DHA-supplemented groups than in the control formula group and comparable to those in reference groups. No developmental test results distinguished these groups. Expected differences in family demographics associated with breastfeeding were found, but no advantages to breastfeeding on any of the developmental outcome demonstrated.ConclusionsThese findings do not support adding AA+DHA to formulas containing 10% energy as linoleic acid and 1% energy as alpha-linolenic acid to enhance growth, visual acuity, information processing, general development, language, or temperament in healthy, term infants during the first 14 months after birth.infant development, breast feeding, infant formula, long-chain polyunsaturated fatty acids, docosahexaenoic acid.

35 keywords...

hide…